GSK163090

产品编号: DC9705 Featured
GSK163090
结构式
844903-58-8
此产品仅供科研所需,我们不出售给病人
​我们将匹配市场上最好的价格给您
Email:order@dcbio.cn
免费咨询电话:4008862077
我们的合作伙伴:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
中国地区超过5000个高品质化合物库存
应用领域
GSK163090是一种有效的选择性5-HT1A/B/D受体拮抗剂,作用于HT1A/B/D和多巴胺D2/D3受体, pKi分别为9.4/8.5/9.7和6.3/6.7。
Cas No.: 844903-58-8
名称:
别名: GSK163090,GSK-163090,GSK 163090
SMILES: CC1=NC2=C(C=C1)C(=CC=C2)N3CCN(CC3)CCC4=CC(=CC=C4)N5CCNC5=O
分子式: C25H29N5O
分子量: 415.53
纯度:
保存条件: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description:
In Vivo:
In Vitro:
References: GSK163090 is a potent, selective, and orally active 5-HT1A/B/D receptor antagonist with pKi of 9.4/8.5/9.7, and 6.3/6.7 for 5-HT1A/B/D, and dopamine D2/D3, respectively. in vitro: GSK163090 demonstrates clear dose-dependent inhibition of the 8-OH-DPAT-induced hyperlocomotor activity (hLMA), with ED50 values ranging from 0.03 to 1 mg/kg. GSK163090 was devoid of agonist activity at R1 receptors, but rather it demonstrated amoderate functional antagonismof the phenylephrineinduced contraction of rabbit aorta (pIC50=6.9). in vivo: Fromamong these analogues, the cyclic urea derivative, GSK163090, emerged due to its low hERG affinity and excellent in vitro DMPK profile. The superior quality of GSK163090 was further highlighted by its commendable in vivo pharmacokinetic profile in rat and its outstanding activity in the 5-HT1A PD model, where 50% efficacy was achieved at a blood concentration of 3 ng/mL. On the basis of these results and its promising preclinical developability profile, GSK163090 was selected as an appropriate development candidate for progression toward clinical proof-of-concept studies.
Kinase Assay:
Cell Assay:
Animal Administration:
References:
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
产品编号 产品名称 应用领域
DC9932 YL-0919 YL0919 是一种口服活性抗抑郁剂,具有双重活性,是一种高选择性的 5-HT uptake 阻滞剂和有效的 5-HT1A receptor 激动剂 (Ki=0.19 nM)。YL0919 对大鼠大脑皮层突触体和 HEK293 细胞摄取 [3H]-5-HT 有抑制作用,IC50s 分别为 1.78 nM 和 1.93 nM。YL0919 在动物模型中表现出明显的抗抑郁作用,对抑郁症的研究具有重要意义。
DC9705 GSK163090 GSK163090是一种有效的选择性5-HT1A/B/D受体拮抗剂,作用于HT1A/B/D和多巴胺D2/D3受体, pKi分别为9.4/8.5/9.7和6.3/6.7。
DC9668 WAY181187.HCl(WAY-181,187) 2-[1-(6-氯-咪唑并[2,1-b]噻唑-5-磺酰基)-1H-吲哚-3-基]-乙胺
DC9322 Ramosetron (Hydrochloride) Ramosetron Hydrochloride(YM060 Hydrochloride) 是一种5 5-HT3 受体拮抗剂,用于治疗恶心和呕吐。
DC9318 Piboserod Piboserod (SB 207266)是5-羟色胺受体5-HT4选择性抑制剂。
DC8795 Pimavanserin(ACP-103) Pimavanserin是选择性的 5-HT2A 受体反向激动剂,pIC50 和 pKd 分别为8.73 and 9.3。
DC8613 Vortioxetine (Lu AA21004) Vortioxetine 是 5-HT1A,5-HT1B,5-HT3A,5-HT7 受体 和 5-羟色胺转运体 (SERT) 的抑制剂,其 Ki 值分别为 15 nM,33 nM,3.7 nM,19 nM 和 1.6 nM。
DC8483 SB-399885 HCl N-(3,5-二氯-2-甲氧基苯基)-4-甲氧基-3-(1-哌嗪基)苯磺酰胺 盐酸盐
DC8354 SB-742457(RVT-101) Intepirdine (SB742457) 是5-HT6受体拮抗剂,pKi为9.63,比对其它受体的抑制性高100倍以上。
DC8334 RS-127445 4-(4-氟-1-萘)-6-(1-甲基乙基)-2-嘧啶胺盐酸盐